obesity drug news today glp-1 september 29 2025 The rate in the US fell in 2023 as GLP-1s go mainstream GLP-1 and Dual GIP/GLP-1 Agonists

Botox injections are superficial and patients find these small pricks to be quick and easy

Keep in mind that the liver and kidneys may be impacted by a high glutathione intake

After more than half a century of bipartisan frustration, its time to acknowledge reality: effective top-down price discipline is impossible, even when underlying costs are falling

GLP-1 agonists bring about similar degrees of weight loss regardless of psychiatric status, but there are reasons to think obesity is different in patients with psychiatric disorders

Feel uneasy about the potential risks of compounded medications, like dosage variability or shipping issues